검색
Glaukos Corp
GKOS관심 목록에 추가
153.580USD
+1.525+1.00%
종가 07-24 16:00（ET）시세는 15분 지연됩니다
9.02B시가총액
손실P/E TTM
자세한 내용은 Glaukos Corp 회사
Glaukos Corporation is an ophthalmic pharmaceutical and medical technology company. The Company is focused on developing and commercializing therapies for the treatment of glaucoma, corneal disorders and retinal diseases. Its commercial solutions and development-stage product candidates include Micro-Invasive Glaucoma Surgery (MIGS) products that primarily involve the insertion of a micro-scale device designed to reduce intraocular pressure (IOP) by restoring the natural aqueous humor outflow pathways for patients suffering from glaucoma; procedural pharmaceuticals based on an intracameral drug delivery technology designed to reduce IOP by delivering therapeutic levels of glaucoma medication from inside the eye over an extended period of time; and bio-activated pharmaceuticals that are intended to strengthen, stabilize, and reshape the cornea for patients impacted by corneal ectatic disorders, such as keratoconus or refractive disorders, among others.
Glaukos Corp 정보
종목 코드 GKOS
회사 이름Glaukos Corp
상장일Jun 25, 2015
CEOBurns (Thomas William)
직원 수995
유형Ordinary Share
회계 연도 종료Jun 25
주소1 Glaukos Way
도시ALISO VIEJO
증권 거래소NASDAQ OMX NASDAQ Basic NYSE
국가United States of America
우편 번호92656
전화19493679600
웹사이트https://www.glaukos.com
종목 코드 GKOS
상장일Jun 25, 2015
CEOBurns (Thomas William)
Glaukos Corp의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Mr. Thomas William Burns
Mr. Thomas William Burns
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.70M
-0.24%
Mr. David F. Hoffmeister
Mr. David F. Hoffmeister
Independent Director
Independent Director
86.97K
+19.41%
Mr. Mark J. Foley
Mr. Mark J. Foley
Lead Independent Director
Lead Independent Director
59.10K
+3.18%
Ms. Aimee S. Weisner, J.D.
Ms. Aimee S. Weisner, J.D.
Independent Director
Independent Director
51.57K
+3.64%
Dr. Tomas Navratil
Dr. Tomas Navratil
Chief Development Officer
Chief Development Officer
47.84K
-1.50%
Mr. Marc A. Stapley
Mr. Marc A. Stapley
Independent Director
Independent Director
38.60K
+4.87%
Dr. Gilbert H. (Gil) Kliman, M.D.
Dr. Gilbert H. (Gil) Kliman, M.D.
Independent Director
Independent Director
--
--
Mr. Joseph E. Gilliam
Mr. Joseph E. Gilliam
President, Chief Operating Officer
President, Chief Operating Officer
--
--
Dr. Leana S. Wen, M.D.
Dr. Leana S. Wen, M.D.
Independent Director
Independent Director
--
--
Ms. Denice M. Torres, J.D.
Ms. Denice M. Torres, J.D.
Independent Director
Independent Director
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Thomas William Burns
Mr. Thomas William Burns
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.70M
-0.24%
Mr. David F. Hoffmeister
Mr. David F. Hoffmeister
Independent Director
Independent Director
86.97K
+19.41%
Mr. Mark J. Foley
Mr. Mark J. Foley
Lead Independent Director
Lead Independent Director
59.10K
+3.18%
Ms. Aimee S. Weisner, J.D.
Ms. Aimee S. Weisner, J.D.
Independent Director
Independent Director
51.57K
+3.64%
Dr. Tomas Navratil
Dr. Tomas Navratil
Chief Development Officer
Chief Development Officer
47.84K
-1.50%
Mr. Marc A. Stapley
Mr. Marc A. Stapley
Independent Director
Independent Director
38.60K
+4.87%
자주 묻는 질문
Glaukos Corp의 상위 5대 주주는 누구인가요?
Glaukos Corp의 상위 5대 주주는 다음과 같습니다: Mr. Thomas William Burns
Glaukos Corp(GKOS)의 주식을 보유한 기관은 몇 개입니까?
2026Q1 기준으로, Glaukos Corp의 주식을 보유한 기관은 총 702곳이며, 이들이 보유한 주식의 총 가치는 약 59.35M로 전체 발행 주식의 101.04%를 차지합니다. 이는 2025Q4 대비 -2784097.00 증가한 수치입니다.
Glaukos Corp의 최대 수익원은 무엇인가요?
2026Q1 기준, Glaukos Corp의 Glaucoma 부문이 가장 높은 매출을 기록했으며, 금액은 421.07M로 전체 매출의 82.98%를 차지했습니다.